solifenacin succinate has been researched along with solifenacin in 1 studies
| Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) | Studies (solifenacin) | Trials (solifenacin) | Recent Studies (post-2010) (solifenacin) |
|---|---|---|---|---|---|
| 522 | 194 | 343 | 14 | 0 | 7 |
| Protein | Taxonomy | solifenacin succinate (IC50) | solifenacin (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 6.3096 | |
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | 4.3 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.024 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Rattus norvegicus (Norway rat) | 6.3096 | |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | 4.3 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.918 | |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | 4.3 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 5.3048 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.3096 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antón, F; Beleta, J; Buil, MA; Cárdenas, A; Casals, G; Castro, J; Córdoba, M; Espinosa, S; Fernández, MD; Ferrer, M; Gavaldà, A; González, M; Huerta, JM; López, M; Miralpeix, M; Monleón, JM; Prat, M; Ramos, I; Ryder, H; Segarra, V; Tort, L; Vilella, D | 1 |
1 other study(ies) available for solifenacin succinate and solifenacin
| Article | Year |
|---|---|
Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists.
Topics: Carbamates; Drug Discovery; Humans; Inhibitory Concentration 50; Microsomes, Liver; Molecular Structure; Muscarinic Antagonists; Quaternary Ammonium Compounds; Quinuclidines; Time Factors | 2011 |